{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:17:52Z","timestamp":1761628672959,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":2089,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1111\/ajt.14039","type":"journal-article","created":{"date-parts":[[2016,9,6]],"date-time":"2016-09-06T10:06:51Z","timestamp":1473156411000},"page":"635-645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys"],"prefix":"10.1016","volume":"17","author":[{"given":"L.","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Dun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kinugasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Higashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Daloze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/ajt.14039_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","article-title":"Mechanism of cellular rejection in transplantation","volume":"25","author":"Ingulli","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/ajt.14039_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1084\/jem.165.2.302","article-title":"Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo","volume":"165","author":"Jenkins","year":"1987","journal-title":"J Exp Med"},{"key":"10.1111\/ajt.14039_bib3","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.4049\/jimmunol.140.10.3324","article-title":"Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells","volume":"140","author":"Jenkins","year":"1988","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14039_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1172\/JCI0214941","article-title":"Activation and inhibition of lymphocytes by costimulation","volume":"109","author":"Frauwirth","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1111\/ajt.14039_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4049\/jimmunol.143.1.153","article-title":"Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes","volume":"143","author":"June","year":"1989","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14039_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.164.1.144","article-title":"CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression","volume":"164","author":"Appleman","year":"2000","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14039_bib7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.86.4.1333","article-title":"CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines\/cytokines","volume":"86","author":"Thompson","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/ajt.14039_bib8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1074-7613(00)80195-8","article-title":"B7\/CD28 costimulation is essential for the homeostasis of the CD4 + CD25 + immunoregulatory T cells that control autoimmune diabetes","volume":"12","author":"Salomon","year":"2000","journal-title":"Immunity"},{"key":"10.1111\/ajt.14039_bib9","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.4049\/jimmunol.157.9.3909","article-title":"CD28\/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation","volume":"157","author":"Sperling","year":"1996","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14039_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMoa050085","article-title":"Costimulation blockade with belatacept in renal transplantation","volume":"353","author":"Vincenti","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14039_bib11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-6143.2009.03005.x","article-title":"A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study)","volume":"10","author":"Vincenti","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","article-title":"Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients","volume":"12","author":"Vincenti","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/protein\/gzw002","article-title":"ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution","volume":"29","author":"Oshima","year":"2016","journal-title":"Protein Eng Des Sel"},{"key":"10.1111\/ajt.14039_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/01.TP.0000440951.29757.bd","article-title":"Pharmacokinetics and pharmacodynamics of ASKP1240, a fully human anti-CD40 antibody, in normal and renal transplanted Cynomolgus monkeys","volume":"97","author":"Ma","year":"2014","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14039_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/micr.20740","article-title":"Surgical complications in kidney transplantation in nonhuman primates","volume":"30","author":"Song","year":"2010","journal-title":"Microsurgery"},{"key":"10.1111\/ajt.14039_bib16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1097\/00007890-200004270-00006","article-title":"Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus","volume":"69","author":"Chen","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14039_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1111\/ajt.14039_bib18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1600-6143.2006.01704.x","article-title":"Pathological and clinical correlates of FOXP3 + cells in renal allografts during acute rejection","volume":"7","author":"Veronese","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/ajt.14039_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: Focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1111\/ajt.14039_bib21","first-page":"1","article-title":"Calcineurin inhibitor-free protocols: Risks and benefits","volume":"18","author":"Barbari","year":"2007","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1111\/ajt.14039_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5500\/wjt.v3.i2.7","article-title":"Is it time to give up with calcineurin inhibitors in kidney transplantation?","volume":"3","author":"Salvadori","year":"2013","journal-title":"World J Transplant"},{"key":"10.1111\/ajt.14039_bib23","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1111\/j.1600-6143.2009.02812.x","article-title":"Mycophenolate mofetil and calcineurin-inhibitor reduction: Recent progress","volume":"9","author":"Griny\u00f3","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib24","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1111\/ajt.12460","article-title":"Long-term belatacept exposure maintains efficacy and safety at 5 years: Results from the long-term extension of the BENEFIT study","volume":"13","author":"Rostaing","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib25","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/ajt.12806","article-title":"Belatacept: Is there BENEFIT for liver transplantation too?","volume":"14","author":"Knechtle","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1074-7613(02)00362-X","article-title":"The interaction properties of costimulatory molecules revisited","volume":"17","author":"Collins","year":"2002","journal-title":"Immunity"},{"key":"10.1111\/ajt.14039_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-7613(94)80021-9","article-title":"Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors","volume":"1","author":"Linsley","year":"1994","journal-title":"Immunity"},{"key":"10.1111\/ajt.14039_bib28","doi-asserted-by":"crossref","first-page":"26762","DOI":"10.1074\/jbc.271.43.26762","article-title":"Covalent dimerization of CD28\/CTLA-4 and oligomerization of CD80\/CD86 regulate T cell costimulatory interactions","volume":"271","author":"Greene","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1111\/ajt.14039_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1254\/jphs.08142FP","article-title":"Efficacy of oral treatment with tacrolimus in the renal transplant model in cynomolgus monkeys","volume":"108","author":"Kinugasa","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/ajt.14039_bib30","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/TP.0b013e31819b5a58","article-title":"Assessment of belatacept mediated costimulation blockade through evaluation of CD80\/86-receptor saturation","volume":"87","author":"Latek","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14039_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nbt1303","article-title":"A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs","volume":"25","author":"Shankar","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1111\/ajt.14039_bib32","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4155\/bio.10.54","article-title":"Unwanted immunogenicity: Lessons learned and future challenges","volume":"2","author":"Wadhwa","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1111\/ajt.14039_bib33","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.4049\/jimmunol.171.7.3348","article-title":"Cutting edge: CD28 controls peripheral homeostasis of CD4 + CD25 + regulatory T cells","volume":"171","author":"Tang","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14039_bib34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMp068087","article-title":"T-cell costimulation\u2013biology, therapeutic potential, and challenges","volume":"355","author":"Sharpe","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/ajt.14039_bib35","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/j.1600-6143.2011.03929.x","article-title":"Deleterious effect of CTLA4-Ig on a Treg-dependent transplant model","volume":"12","author":"Riella","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/TP.0b013e31829f1607","article-title":"Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans","volume":"96","author":"Levitsky","year":"2013","journal-title":"Transplantation"},{"key":"10.1111\/ajt.14039_bib37","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/j.1600-6143.2012.04184.x","article-title":"CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells","volume":"12","author":"Charbonnier","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib38","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.4049\/jimmunol.166.3.1572","article-title":"CTLA4Ig-induced linked regulation of allogeneic T cell responses","volume":"166","author":"Lee","year":"2001","journal-title":"J Immunol"},{"key":"10.1111\/ajt.14039_bib39","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1111\/j.1600-6143.2008.02377.x","article-title":"The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation","volume":"8","author":"Bluestone","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1111\/ajt.14039_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fimmu.2011.00039","article-title":"Role of dendritic cell maturity\/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells","volume":"2","author":"Pletinckx","year":"2011","journal-title":"Front Immunol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.14039","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522248941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522248941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajt.14039\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:14:38Z","timestamp":1761628478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522248941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1600613522248941"],"URL":"https:\/\/doi.org\/10.1111\/ajt.14039","relation":{},"ISSN":["1600-6135"],"issn-type":[{"type":"print","value":"1600-6135"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.14039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}